Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzyme Substitution in Exocrine Pancreatic Insufficiency: Self Administration vs Fixed Dose
NCT01430234Phase 4Completed
- Sponsor
- Foundation for Liver Research
- Start
- Oct 2011
- Primary completion
- Feb 2013
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by Foundation for Liver Research. Started Oct 2011; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT01430234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01430234.